Barclays analyst Andrew Mok raised the firm’s price target on Brookdale Senior Living (BKD) to $15 from $14 and keeps an Overweight rating on the shares. The firm adjusted targets in the healthcare facilities and managed care group as part of a preview of 2026 outlooks.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BKD:
- Brookdale Senior Living Reports Strong Occupancy Momentum Into 2026
- Brookdale Senior Living announces December occupancy of 82.4%
- Brookdale Senior Living double upgraded to Buy at BofA
- Brookdale Senior Living upgraded to Buy from Underperform at BofA
- Brookdale Senior Living announces November occupancy of 82.5%